Table of Contents Author Guidelines Submit a Manuscript

Citations to this Journal [982 citations: 1–100 of 940 articles]

Articles published in Prostate Cancer have been cited 982 times. The following is a list of the 940 articles that have cited the articles published in Prostate Cancer.

  • Steven Kammann, Christine Menias, Amy Hara, Mariam Moshiri, Cary Siegel, Bashar Safar, Steven Brandes, Akram Shaaban, and Kumar Sandrasegaran, “Genital and reproductive organ complications of Crohn disease: technical considerations as it relates to perianal disease, imaging features, and implications on management,” Abdominal Radiology, 2017. View at Publisher · View at Google Scholar
  • H. Xu, P.D. Bai, M.B. Hu, S.H. Mao, W.H. Zhu, J.M. Hu, S.H. Liu, T. Yang, J.Y. Hou, Y. Hu, Q. Ding, and H.W. Jiang, “Gleason sum upgrading between biopsy and radical prostatectomy in Chinese population: Updated nomograms,” Actas Urológicas Españolas (English Edition), 2017. View at Publisher · View at Google Scholar
  • Tobias Pommer, Jung Hun Oh, Per Munck af Rosenschöld, and Joseph O. Deasy, “Simulating intrafraction prostate motion with a random walk model,” Advances in Radiation Oncology, 2017. View at Publisher · View at Google Scholar
  • B. Yeboah-Asiamah, D. Yirenya-Tawiah, D. Baafi, and M.M. Ackumey, “Perceptions and knowledge about prostate cancer and attitudes towards prostate cancer screening among male teachers in the Sunyani Municipality, Ghana,” African Journal of Urology, 2017. View at Publisher · View at Google Scholar
  • Motolani E. Ogunsanya, Carolyn M. Brown, Folakemi T. Odedina, Jamie C. Barner, Taiwo B. Adedipe, and Brittany Corbell, “Knowledge of Prostate Cancer and Screening Among Young Multiethnic Black Men,” American Journal of Men's Health, pp. 155798831668949, 2017. View at Publisher · View at Google Scholar
  • Halina Jurkowska, Maria Wróbel, Marta Kaczor-Kamińska, and Ewa Jasek-Gajda, “A possible mechanism of inhibition of U87MG and SH-SY5Y cancer cell proliferation by diallyl trisulfide and other aspects of its activity,” Amino Acids, 2017. View at Publisher · View at Google Scholar
  • Erin O’Leary, Daniela Iacoboni, Jennifer Holle, Scott T. Michalski, Edward D. Esplin, Shan Yang, and Karen Ouyang, “Expanded Gene Panel Use for Women With Breast Cancer: Identification and Intervention Beyond Breast Cancer Risk,” Annals of Surgical Oncology, 2017. View at Publisher · View at Google Scholar
  • Avinash Kumar, Agnes M. Rimando, and Anait S. Levenson, “Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer,” Annals of the New York Academy of Sciences, 2017. View at Publisher · View at Google Scholar
  • Colin P. Bergstrom, Brian Ruffell, Christine M.T. Ho, Celestia S. Higano, William J. Ellis, Mark Garzotto, Tomasz M. Beer, and Julie N. Graff, “Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer,” Anti-Cancer Drugs, vol. 28, no. 1, pp. 120–126, 2017. View at Publisher · View at Google Scholar
  • Alessandro Bertaccini, Vincenzo Scattoni, Pietro Pepe, Caterina Gaudiano, Roberta Gunelli, Pasquale Martino, Andrea Fandella, Vittorino Montanaro, Rodolfo Montironi, Tiziana Pierangeli, Armando Stabile, Andrea Galosi, Michelangelo Fiorentino, and Marco Giampaoli, “Italian prostate biopsies group: 2016 updated guidelines insights,” Anticancer Research, vol. 37, no. 2, pp. 413–424, 2017. View at Publisher · View at Google Scholar
  • Soon Auck Hong, Ki Hong Kim, Tae Jin Lee, Eon Sub Park, Mi Kyung Kim, and Soon Chul Myung, “A role of human beta defensin-1 in predicting prostatic adenocarcinoma in cases of false-negative biopsy,” Apmis, 2017. View at Publisher · View at Google Scholar
  • Niyaz Ahmad, Md Aftab Alam, Rizwan Ahmad, Atta Abbas Naqvi, and Farhan Jalees Ahmad, “Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer,” Artificial Cells, Nanomedicine, and Biotechnology, pp. 1–15, 2017. View at Publisher · View at Google Scholar
  • N. P. Akentieva, and S. S. Shushanov, “Inhibition of cancer cell invasiveness by synthetic peptides GEGEEGEE and DFGEEAEE,” Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology, vol. 11, no. 1, pp. 24–34, 2017. View at Publisher · View at Google Scholar
  • Jonathan Boucher, Arnaud Monvoisin, Justine Vix, Marc Mesnil, Dominique Thuringer, Françoise Debiais, and Laurent Cronier, “Connexins, important players in the dissemination of prostate cancer cells,” Biochimica et Biophysica Acta (BBA) - Biomembranes, 2017. View at Publisher · View at Google Scholar
  • Tianci Song, Yanchun Liang, Zhongbo Cao, Wei Du, and Ying Li, “Computational Analysis of Specific MicroRNA Biomarkers for Noninvasive Early Cancer Detection,” BioMed Research International, vol. 2017, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  • Pu Li, Chenkui Miao, Chao Liang, Pengfei Shao, Zengjun Wang, and Jie Li, “Silencing CAPN2 Expression Inhibited Castration-Resistant Prostate Cancer Cells Proliferation and Invasion via AKT/mTOR Signal Pathway,” BioMed Research International, vol. 2017, pp. 1–10, 2017. View at Publisher · View at Google Scholar
  • Andr?s L?pez-Cort?s, Alejandro Cabrera-Andrade, Carolina Salazar-Ruales, Ana Karina Zambrano, Santiago Guerrero, Patricia Guevara, Paola E. Leone, and C?sar Paz-y-Mi?o, “Genotyping the High Altitude Mestizo Ecuadorian Population Affected with Prostate Cancer,” BioMed Research International, vol. 2017, pp. 1–10, 2017. View at Publisher · View at Google Scholar
  • Jieke Yan, Yuzhen Wang, Yuxiu Jia, Shuangde Liu, Chuan Tian, Wengu Pan, Xiaoli Liu, and Hongwei Wang, “Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer,” Biomedicine & Pharmacotherapy, vol. 88, pp. 374–383, 2017. View at Publisher · View at Google Scholar
  • Wen-bin Zhu, Fu-jun Tian, and Li-qian Liu, “Chikusetsu (CHI) triggers mitochondria-regulated apoptosis in human prostate cancer via reactive oxygen species (ROS) production,” Biomedicine & Pharmacotherapy, vol. 90, pp. 446–454, 2017. View at Publisher · View at Google Scholar
  • Ashanul Haque, Md. Serajul Haque Faizi, Jahangir Ahmad Rather, and Muhammad S. Khan, “Next Generation NIR Fluorophores for Tumor Imaging and Fluorescence-Guided Surgery: A review,” Bioorganic & Medicinal Chemistry, 2017. View at Publisher · View at Google Scholar
  • Koh Meng Aw Yong, Yubing Sun, Sofia D. Merajver, and Jianping Fu, “Mechanotransduction-Induced Reversible Phenotypic Switching in Prostate Cancer Cells,” Biophysical Journal, vol. 112, no. 6, pp. 1236–1245, 2017. View at Publisher · View at Google Scholar
  • Marjolaine Ngollo, Andre Lebert, Marine Daures, Gaelle Judes, Khaldoun Rifai, Lucas Dubois, Jean-Louis Kemeny, Frederique Penault-Llorca, Yves-Jean Bignon, Laurent Guy, and Dominique Bernard-Gallon, “Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression,” BMC Cancer, vol. 17, no. 1, 2017. View at Publisher · View at Google Scholar
  • Sanna Hallamies, Liisa M. Pelttari, Paula Poikonen-Saksela, Antti Jekunen, Arja Jukkola-Vuorinen, Päivi Auvinen, Carl Blomqvist, Kristiina Aittomäki, Johanna Mattson, and Heli Nevanlinna, “CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population,” BMC Cancer, vol. 17, no. 1, 2017. View at Publisher · View at Google Scholar
  • Luc Beaulieu, Emmanuel Racine, Dae Yup Han, Eric Vigneault, I-Chow Hsu, and J. Adam M. Cunha, “Real-time electromagnetic tracking–based treatment platform for high-dose-rate prostate brachytherapy: Clinical workflows and end-to-end validation,” Brachytherapy, 2017. View at Publisher · View at Google Scholar
  • P. Blanchard, C. Ménard, and S.J. Frank, “Clinical use of magnetic resonance imaging across the prostate brachytherapy workflow,” Brachytherapy, 2017. View at Publisher · View at Google Scholar
  • A.M. Venkatesan, R.J. Stafford, C. Duran, P.D. Soni, A. Berlin, and P.W. McLaughlin, “Prostate MRI for brachytherapists: Anatomy and technique,” Brachytherapy, 2017. View at Publisher · View at Google Scholar
  • Rajat J. Kudchadker, Firas Mourtada, Jihong Wang, Kari Tanderup, Adam Cunha, Antonio L. Damato, and Gil'ad N. Cohen, “Magnetic resonance imaging basics for the prostate brachytherapist,” Brachytherapy, 2017. View at Publisher · View at Google Scholar
  • Archana Mukhopadhyay, Laura E. Hanold, Hamsa Thayele Purayil, Solomon Gisemba, Sanjeewa Senadheera, and Jane V. Aldrich, “Macrocyclic peptides decrease c-Myc protein levels and reduce prostate cancer cell growth,” Cancer Biology & Therapy, pp. 00–00, 2017. View at Publisher · View at Google Scholar
  • Shravana Kumar Jyoti, Camille Blacke, Pallavi Patil, Vibha P. Amblihalli, and Amanda Nicholson, “Prostate cancer screening by prostate-specific antigen (PSA); a relevant approach for the small population of the Cayman Islands,” Cancer Causes & Control, 2017. View at Publisher · View at Google Scholar
  • Marshall K. Tulloch-Reid, Norma McFarlane-Anderson, Franklyn I. Bennett, William D. Aiken, and Maria D. Jackson, “Effects of cholesterol, C-reactive protein, and interleukin-6 on prostate cancer risk in a population of African ancestry,” Cancer Causes & Control, 2017. View at Publisher · View at Google Scholar
  • Nagi B. Kumar, Julio M. Pow-Sang, Philippe E. Spiess, Jong Y. Park, Ganna Chornokur, Andrew R. Leone, and Catherine M. Phelan, “Chemoprevention in African American Men with Prostate Cancer,” Cancer Control, vol. 23, no. 4, pp. 415–423, 2017. View at Publisher · View at Google Scholar
  • Paulo S. Pinheiro, Karen E. Callahan, Camille Ragin, Robert W. Hage, Tara Hylton, and Erin N. Kobetz, “Black Heterogeneity in Cancer Mortality: US-Blacks, Haitians, and Jamaicans,” Cancer Control, vol. 23, no. 4, pp. 347–358, 2017. View at Publisher · View at Google Scholar
  • Rishika Banydeen, Angela M.C. Rose, Damali Martin, William Aiken, Cheryl Alexis, Glennis Andall-Brereton, Kimlin Ashing, J. Gordon Avery, Penny Avery, Jacqueline Deloumeaux, Natasha Ekomaye, Owen Gabriel, Trevor Hassell, Lowell Hughes, Maisha Hutton, Shravana Kumar Jyoti, Penelope Layne, Danièle Luce, Alan Patrick, Patsy Prussia, Juliette Smith-Ravin, Jacqueline Veronique-Baudin, Elizabeth Blackman, Veronica Roach, and Camille Ragin, “Advancing Cancer Control through Research and Cancer Registry Collaborations in the Caribbean,” Cancer Control, vol. 22, no. 4, pp. 520–530, 2017. View at Publisher · View at Google Scholar
  • Rajnee Kanwal, Alexis R. Plaga, Xiaoqi Liu, Girish C. Shukla, and Sanjay Gupta, “MicroRNAs in prostate cancer: Functional role as biomarkers,” Cancer Letters, 2017. View at Publisher · View at Google Scholar
  • Bryan Hoang, Mark J. Ernsting, Wei-Hsin Sophia Tang, Joseph Bteich, Elijus Undzys, Taira Kiyota, and Shyh-Dar Li, “Cabazitaxel-Conjugated Nanoparticles for Docetaxel-Resistant and Bone Metastatic Prostate Cancer,” Cancer Letters, 2017. View at Publisher · View at Google Scholar
  • Masaru Takagi, Yusuke Demizu, Kazuki Terashima, Osamu Fujii, Dongcun Jin, Yasue Niwa, Takashi Daimon, Masao Murakami, Nobukazu Fuwa, and Tomoaki Okimoto, “Long-term outcomes in patients treated with proton therapy for localized prostate cancer,” Cancer Medicine, 2017. View at Publisher · View at Google Scholar
  • Guilherme O. Barbosa, Nilva K. Cervigne, Hernandes F. Carvalho, and Taize M. Augusto, “Heparanase 1 involvement in prostate physiopathology,” Cell Biology International, 2017. View at Publisher · View at Google Scholar
  • Jamie Josephine Avila McLeod, Heather L. Caslin, Andrew J. Spence, Elizabeth M. Kolawole, Amina Abdul Qayum, Anuya Paranjape, Marcela Taruselli, Tamara T. Haque, Kasalina N. Kiwanuka, Howard L. Elford, and John J. Ryan, “Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IgE-mediated mast cell activation through attenuation of NFκB and AP-1 transcription,” Cellular Immunology, 2017. View at Publisher · View at Google Scholar
  • M. Bonet, L. Cayetano, M. Núñez, E. Jovell-Fernández, A. Aguilar, and Y. Ribas, “Assessment of acute bowel function after radiotherapy for prostate cancer: Is it accurate enough?,” Clinical and Translational Oncology, 2017. View at Publisher · View at Google Scholar
  • Apostolos Gaitanidis, Michail Alevizakos, Christos Tsalikidis, Alexandra Tsaroucha, Constantinos Simopoulos, and Michail Pitiakoudis, “Refusal of cancer-directed surgery by breast cancer patients: risk factors and survival outcomes,” Clinical Breast Cancer, 2017. View at Publisher · View at Google Scholar
  • Robert Scott Libby, Jordan J. Kramer, Hoang Minh Tue Nguyen, Allison Feibus, Raju Thomas, and Jonathan Silberstein, “Racial variation in the outcome of subsequent prostate biopsies in men with an initial diagnosis of atypical small acinar proliferation (ASAP),” Clinical Genitourinary Cancer, 2017. View at Publisher · View at Google Scholar
  • Wan Song, Joon Hyung Park, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, and Han Yong Choi, “Comparison of Oncologic Outcomes and Complications by Surgical Approach to Radical Prostatectomy: Special Focus on Perineal Approach,” Clinical Genitourinary Cancer, 2017. View at Publisher · View at Google Scholar
  • Nuno Adubeiro, Maria Luísa Nogueira, Rita G. Nunes, Hugo Alexandre Ferreira, Eduardo Ribeiro, and José Maria Ferreira La Fuente, “Apparent diffusion coefficient in the analysis of prostate cancer: determination of optimal b-value pair to differentiate normal from malignant tissue,” Clinical Imaging, 2017. View at Publisher · View at Google Scholar
  • Joelle El-Amm, and Jeanny B. Aragon-Ching, “Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer,” Clinical Medicine Insights: Oncology, vol. 10s1, pp. CMO.Ss30751, 2017. View at Publisher · View at Google Scholar
  • Vipin Lohiya, Jeanny B. Aragon-Ching, and Guru Sonpavde, “Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer,” Clinical Medicine Insights: Oncology, vol. 10s1, pp. CMO.S34535, 2017. View at Publisher · View at Google Scholar
  • Francesca Sanguedolce, Antonella Cormio, Giovanni Musci, Francesco Troiano, Giuseppe Carrieri, Pantaleo Bufo, and Luigi Cormio, “Typing the atypical: Diagnostic issues and predictive markers in suspicious prostate lesions,” Critical Reviews in Clinical Laboratory Sciences, pp. 1–17, 2017. View at Publisher · View at Google Scholar
  • Zachary Z. Reinstein, Sahithi Pamarthy, Vinay Sagar, Ricardo Costa, Sarki A. Abdulkadir, Francis J. Giles, and Benedito A. Carneiro, “Overcoming immunosuppression in bone metastases,” Critical Reviews in Oncology/Hematology, 2017. View at Publisher · View at Google Scholar
  • Alfonso Fasano, Andres M. Lozano, and Esther Cubo, “New neurosurgical approaches for tremor and Parkinson?s disease,” Current Opinion in Neurology, vol. 30, no. 4, pp. 435–446, 2017. View at Publisher · View at Google Scholar
  • Ulka N. Vaishampayan, “Changing face of metastatic prostate cancer,” Current Opinion in Oncology, vol. 29, no. 3, pp. 196–200, 2017. View at Publisher · View at Google Scholar
  • Adrian Rhudd, Jean McDonald, Mark Emberton, and Veeru Kasivisvanathan, “The role of the multiparametric MRI in the diagnosis of prostate cancer in biopsy-naïve men,” Current Opinion in Urology, vol. 27, no. 5, pp. 488–494, 2017. View at Publisher · View at Google Scholar
  • Justin T. Matulay, and G. Joel DeCastro, “Radical Prostatectomy for High-risk Localized or Node-Positive Prostate Cancer: Removing the Primary,” Current Urology Reports, vol. 18, no. 7, 2017. View at Publisher · View at Google Scholar
  • Brendan Michael Browne, and Alex J. Vanni, “Management of Urethral Stricture and Bladder Neck Contracture Following Primary and Salvage Treatment of Prostate Cancer,” Current Urology Reports, vol. 18, no. 10, 2017. View at Publisher · View at Google Scholar
  • A. Y. Al-Yasiri, M. Khoobchandani, C. S. Cutler, L. Watkinson, T. Carmack, C. J. Smith, M. Kuchuk, S. K. Loyalka, A. B. Lugão, and K. V. Katti, “ Mangiferin functionalized radioactive gold nanoparticles (MGF- 198 AuNPs) in prostate tumor therapy: green nanotechnology for production, in vivo tumor retention and evaluation of therapeutic efficacy ,” Dalton Trans., 2017. View at Publisher · View at Google Scholar
  • F. Steinkohl, A. Luger, J. Bektic, and F. Aigner, “Ultraschall der Prostata,” Der Radiologe, 2017. View at Publisher · View at Google Scholar
  • G. Chevreau, “Biopsias prostáticas: indicaciones y técnicas,” EMC - Urología, vol. 49, no. 2, pp. 1–12, 2017. View at Publisher · View at Google Scholar
  • Masaki Shiota, Akira Yokomizo, Ario Takeuchi, Eiji Kashiwagi, Takashi Dejima, Junichi Inokuchi, Katsunori Tatsugami, Takeshi Uchiumi, and Masatoshi Eto, “Protein kinase C regulates Twist1 expression via NF-κB in prostate cancer,” Endocrine-Related Cancer, vol. 24, no. 4, pp. 171–180, 2017. View at Publisher · View at Google Scholar
  • Stephen J Foulkes, Robin M Daly, and Steve F Fraser, “The clinical importance of quantifying body fat distribution during androgen deprivation therapy for prostate cancer,” Endocrine-Related Cancer, vol. 24, no. 3, pp. R35–R48, 2017. View at Publisher · View at Google Scholar
  • Roberta Visconti, and Domenico Grieco, “Fighting tubulin-targeting anticancer drug toxicity and resistance,” Endocrine-Related Cancer, vol. 24, no. 9, pp. T107–T117, 2017. View at Publisher · View at Google Scholar
  • O. Bamidele, H. McGarvey, B.M. Lagan, N. Ali, F. Chinegwundoh MBE, K. Parahoo, and E. McCaughan, “Life after prostate cancer: A systematic literature review and thematic synthesis of the post-treatment experiences of Black African and Black Caribbean men,” European Journal of Cancer Care, pp. e12784, 2017. View at Publisher · View at Google Scholar
  • Iztok Caglic, Nienke L. Hansen, Rhys A. Slough, Andrew J. Patterson, and Tristan Barrett, “Evaluating the effect of rectal distension on prostate multiparametric MRI image quality,” European Journal of Radiology, vol. 90, pp. 174–180, 2017. View at Publisher · View at Google Scholar
  • Archana Anantharaman, and Eric J. Small, “Tackling non-metastatic castration-resistant prostate cancer: special considerations in treatment,” Expert Review of Anticancer Therapy, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  • Swati Dhar, Avinash Kumar, Christian R. Gomez, Israh Akhtar, John C. Hancock, Janice M. Lage, Charles R. Pound, and Anait S. Levenson, “MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness,” FEBS Letters, 2017. View at Publisher · View at Google Scholar
  • Wei Jia, Wenyuan Liu, Si Mi, Chunhui Zhang, Xia Li, Ting Wu, and Qunli Yu, “Comparison of Six Methylation Methods for Fatty Acid Determination in Yak Bone Using Gas Chromatography,” Food Analytical Methods, 2017. View at Publisher · View at Google Scholar
  • Hélder Oliveira, Xiaoshuang Cai, Qian Zhang, Victor de Freitas, Nuno Mateus, Jingren He, and Iva Fernandes, “Gastrointestinal absorption, antiproliferative and anti-inflammatory effect of the major carotenoids of Gardenia jasminoides Ellis on cancer cells,” Food Funct., 2017. View at Publisher · View at Google Scholar
  • Rachel E. Crossland, Jean Norden, Mateja Kralj Juric, Kile Green, Kim F. Pearce, Clare Lendrem, Hildegard T. Greinix, and Anne M. Dickinson, “Expression of Serum microRNAs is Altered During Acute Graft-versus-Host Disease,” Frontiers in Immunology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Mateja Kralj Juric, Maxim Shevtsov, Petra Mozes, Justyna Ogonek, Rachel E. Crossland, Anne M. Dickinson, Hildegard T. Greinix, Ernst Holler, Eva M. Weissinger, and Gabriele Multhoff, “B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation,” Frontiers in Immunology, vol. 7, 2017. View at Publisher · View at Google Scholar
  • Priyanka Dhingra, Alexander Martinez-Fundichely, Adeline Berger, Franklin W. Huang, Andre Neil Forbes, Eric Minwei Liu, Deli Liu, Andrea Sboner, Pablo Tamayo, David S. Rickman, Mark A. Rubin, and Ekta Khurana, “Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network,” Genome Biology, vol. 18, no. 1, 2017. View at Publisher · View at Google Scholar
  • Leif E. Peterson, and Tatiana Kovyrshina, “Progression inference for somatic mutations in cancer,” Heliyon, vol. 3, no. 4, pp. e00277, 2017. View at Publisher · View at Google Scholar
  • Wei Tian, David Dorn, Shi Wei, Ronald D Sanders, Andres Matoso, Rajal B Shah, and Jennifer Gordetsky, “GATA3 expression in benign prostate glands with radiation atypia: a diagnostic pitfall,” Histopathology, 2017. View at Publisher · View at Google Scholar
  • Megan S. Farris, Karen A. Kopciuk, Kerry S. Courneya, S. Elizabeth McGregor, Qinggang Wang, and Christine M. Friedenreich, “Identification and prediction of health-related quality of life trajectories after a prostate cancer diagnosis,” International Journal of Cancer, 2017. View at Publisher · View at Google Scholar
  • Zubing Mei, Mining Liang, Lezhi Li, Yi Zhang, Qingming Wang, and Wei Yang, “Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals,” International Journal of Cancer, vol. 140, no. 5, pp. 1068–1081, 2017. View at Publisher · View at Google Scholar
  • Gustavo Arruda Viani, and Aline Sakamoto, “Outpatient application of formalin for chronic rectal bleeding after prostate irradiation: a quasi-experimental study,” International Journal of Colorectal Disease, 2017. View at Publisher · View at Google Scholar
  • Na-Kyung Han, Ye Ji Jeong, Bo-Jeong Pyun, Yoon-Jin Lee, Sung-Ho Kim, and Hae-June Lee, “Geranylgeranylacetone Ameliorates Intestinal Radiation Toxicity by Preventing Endothelial Cell Dysfunction,” International Journal of Molecular Sciences, vol. 18, no. 10, pp. 2103, 2017. View at Publisher · View at Google Scholar
  • Andrea Iorga, Lily Dara, and Neil Kaplowitz, “Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis,” International Journal of Molecular Sciences, vol. 18, no. 5, pp. 1018, 2017. View at Publisher · View at Google Scholar
  • Subbroto Kumar Saha, Soo Bin Lee, Jihye Won, Hye Yeon Choi, Kyeongseok Kim, Gwang-Mo Yang, Ahmed Abdal Dayem, and Ssang-goo Cho, “Correlation between Oxidative Stress, Nutrition, and Cancer Initiation,” International Journal of Molecular Sciences, vol. 18, no. 7, pp. 1544, 2017. View at Publisher · View at Google Scholar
  • Michael Puccinelli, and Silvia Stan, “Dietary Bioactive Diallyl Trisulfide in Cancer Prevention and Treatment,” International Journal of Molecular Sciences, vol. 18, no. 8, pp. 1645, 2017. View at Publisher · View at Google Scholar
  • Elizabeth Hull, McKale Montgomery, and Kathryn Leyva, “Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers,” International Journal of Molecular Sciences, vol. 18, no. 7, pp. 1361, 2017. View at Publisher · View at Google Scholar
  • Paul W. Ewald, “Ancient cancers and infection-induced oncogenesis,” International Journal of Paleopathology, 2017. View at Publisher · View at Google Scholar
  • Alexandru Nicolae, Gerard Morton, Hans Chung, Andrew Loblaw, Suneil Jain, Darren Mitchell, Lin Lu, Joelle Helou, Motasem Al-Hanaqta, Emily Heath, and Ananth Ravi, “Evaluation of a Machine-Learning Algorithm for Treatment Planning in Prostate Low-Dose-Rate Brachytherapy,” International Journal of Radiation Oncology*Biology*Physics, vol. 97, no. 4, pp. 822–829, 2017. View at Publisher · View at Google Scholar
  • Kevin Martell, Siraj Husain, Daniel Taussky, Steve Angyalfi, Guila Delouya, Philippe Després, Luc Beaulieu, Andre-Guy Martin, and Eric Vigneault, “Multicenter Evaluation of Biochemical Relapse–Free Survival Outcomes for Intraoperatively Planned Prostate Brachytherapy Using an Automated Delivery System,” International Journal of Radiation Oncology*Biology*Physics, 2017. View at Publisher · View at Google Scholar
  • Bijaya Malla, Kathrin Zaugg, Erik Vassella, Daniel M. Aebersold, and Alan Dal Pra, “Exosomes and Exosomal MicroRNAs in Prostate Cancer Radiation Therapy,” International Journal of Radiation Oncology*Biology*Physics, vol. 98, no. 5, pp. 982–995, 2017. View at Publisher · View at Google Scholar
  • G. Moretto, A. Casaril, and M. Inama, “Use of biological mesh in trans-anal treatment for recurrent recto-urethral fistula,” International Urology and Nephrology, 2017. View at Publisher · View at Google Scholar
  • Tong Zhang, Haihu Wu, Shuai Liu, Wei He, and Kejia Ding, “Clinical evaluation of tamsulosin in the relief of lower urinary tract symptoms in advanced prostate cancer patients,” International Urology and Nephrology, 2017. View at Publisher · View at Google Scholar
  • Findlay MacAskill, Su-Min Lee, David Eldred-Evans, Wahyu Wulaningsih, Rick Popert, Konrad Wolfe, Mieke Van Hemelrijck, Giles Rottenberg, Sidath H. Liyanage, and Peter Acher, “Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes,” International Urology and Nephrology, 2017. View at Publisher · View at Google Scholar
  • Yoshiyasu Amiya, Yasutaka Yamada, Masahiro Sugiura, Makoto Sasaki, Takayuki Shima, Noriyuki Suzuki, Hiroomi Nakatsu, Shino Murakami, and Jun Shimazaki, “Treatment of locally advanced prostate cancer (Stage T3),” Japanese Journal of Clinical Oncology, 2017. View at Publisher · View at Google Scholar
  • Susana Cruz-Neves, Nilza Ribeiro, Inês Graça, Carmen Jerónimo, Susana R. Sousa, and Fernando J. Monteiro, “Behavior of prostate cancer cells in a nanohydroxyapatite/collagen bone scaffold,” Journal of Biomedical Materials Research Part A, 2017. View at Publisher · View at Google Scholar
  • Ewan K. Cobran, Jori N. Hall, and William D. Aiken, “African-American and Caribbean-Born Men’s Perceptions of Prostate Cancer Fear and Facilitators for Screening Behavior: a Pilot Study,” Journal of Cancer Education, 2017. View at Publisher · View at Google Scholar
  • Lipsa Das, Todd A. Anderson, Jaime M.C. Gard, Isis C. Sroka, Stephanie R. Strautman, Raymond B. Nagle, Colm Morrissey, Beatrice S. Knudsen, and Anne E. Cress, “Characterization of Laminin Binding Integrin Internalization in Prostate Cancer Cells,” Journal of Cellular Biochemistry, 2017. View at Publisher · View at Google Scholar
  • A.M. Decker, F.C. Cackowski, Y. Jung, and R.S. Taichman, “Biochemical Changes in the Niche Following Tumor Cell Invasion,” Journal of Cellular Biochemistry, 2017. View at Publisher · View at Google Scholar
  • Keisei Okamoto, Naoaki Kohno, and Akinori Wada, “High biologically effective dose radiation therapy using brachytherapy in combination with external beam radiotherapy for high-risk prostate cancer,” Journal of Contemporary Brachytherapy, vol. 9, no. 1, pp. 1–6, 2017. View at Publisher · View at Google Scholar
  • Teck Wei Tan, Keng Siang Png, Chau Hung Lee, Arianto Yuwono, Yuyi Yeow, Kian-Tai Chong, Yee Mun Lee, Cher Heng Tan, and Yung Khan Tan, “MRI-fusion targeted transrectal prostate biopsy and the role of prostate specific antigen density and prostate health index for the detection of clinically significant prostate cancer in Southeast Asian men,” Journal of Endourology, 2017. View at Publisher · View at Google Scholar
  • Okon Ekwere Essien, Iya Eze Bassey, Rebecca Mtaku Gali, Alphonsus Ekpe Udoh, Uwem Okon Akpan, and Enakirerhi E. Glen, “Cardiovascular Disease Risk Factors: How Relevant in African Men With Prostate Cancer Receiving Androgen-Deprivation Therapy?,” Journal of Global Oncology, vol. 3, no. 1, pp. 7–14, 2017. View at Publisher · View at Google Scholar
  • Vanessa M. Hayes, and M.S. Riana Bornman, “Prostate Cancer in Southern Africa: Does Africa Hold Untapped Potential to Add Value to the Current Understanding of a Common Disease?,” Journal of Global Oncology, pp. JGO.2016.008862, 2017. View at Publisher · View at Google Scholar
  • Shengnan Yu, Anping Li, Qian Liu, Xun Yuan, Hanxiao Xu, Dechao Jiao, Richard G. Pestell, Xinwei Han, and Kongming Wu, “Recent advances of bispecific antibodies in solid tumors,” Journal of Hematology & Oncology, vol. 10, no. 1, 2017. View at Publisher · View at Google Scholar
  • Yuma Waseda, Soichiro Yoshida, Taro Takahara, Thomas Christian Kwee, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, and Yasuhisa Fujii, “Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer,” Journal of Magnetic Resonance Imaging, 2017. View at Publisher · View at Google Scholar
  • Satheesh Krishna, Christopher S. Lim, Matthew D.F. McInnes, Trevor A. Flood, Wael M. Shabana, Robert S. Lim, and Nicola Schieda, “Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer,” Journal of Magnetic Resonance Imaging, 2017. View at Publisher · View at Google Scholar
  • Eman M. Saied, and Hanan Alsaeid Alshenawy, “Prostatic carcinogenesis: More insights,” Journal of Microscopy and Ultrastructure, 2017. View at Publisher · View at Google Scholar
  • Christine M. Friedenreich, Eileen Shaw, Heather K. Neilson, and Darren R. Brenner, “Epidemiology and biology of physical activity and cancer recurrence,” Journal of Molecular Medicine, 2017. View at Publisher · View at Google Scholar
  • Fergus V. Coakley, Aytekin Oto, Lauren F. Alexander, Brian C. Allen, Brian J. Davis, Adam T. Froemming, Pat F. Fulgham, Keyanoosh Hosseinzadeh, Christopher Porter, V. Anik Sahni, David M. Schuster, Timothy N. Showalter, Aradhana M. Venkatesan, Sadhna Verma, Carolyn L. Wang, Erick M. Remer, and Steven C. Eberhardt, “ACR Appropriateness Criteria ® Prostate Cancer—Pretreatment Detection, Surveillance, and Staging,” Journal of the American College of Radiology, vol. 14, no. 5, pp. S245–S257, 2017. View at Publisher · View at Google Scholar
  • Antoinette Percy-Laurry, Sean F. Altekruse, Mian B. Hossain, Anne Marie O'Keefe, Norman J. Johnson, and Farin Kamangar, “Association Between Socioeconomic Status and Tumor Grade Among Black Men with Prostate Cancer,” Journal of the National Medical Association, 2017. View at Publisher · View at Google Scholar